fda glp-1 warning letters news Beyond the Headlines: to Compounders FEDS CRACK DOWN ON TELEHEALTH

Dose timing, storage discipline, and reconstitution technique aren't secondary considerations

The FDA approved Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who are also overweight in March 2024, which opened the door for Medicare coverage in that specific population

GLP-1 drugs are so effective because they reduce hunger and cravings

These may include: Nausea Vomiting Diarrhea Constipation Bloating or gas Decreased appetite Fatigue To minimize side effects, its important to start with a lower dose and gradually increase as tolerated

**Cons:** Wednesday can feel like peak work intensity

In one study on children and adolescents, neurofeedback was as effective as methylphenidate in treating attention and hyperactivity symptoms